H2 vs NAC vs glutathione: 3 antioxidants compared

Three molecules dominate the antioxidant conversation among informed biohackers: N-acetylcysteine (NAC), glutathione (oral or liposomal), and molecular hydrogen (H₂). All three are described as "the best antioxidant" by their respective promoters. The reality is more nuanced: each acts under a different logic, with distinct bioavailabilities, selectivities and safety profiles.

This comparison draws on two key studies (Ohsawa 2007 in Nature Medicine and Iuchi 2016 in Free Radical Research) to distinguish the specificity of H₂, without demonising or overstating NAC or glutathione. Objective: enable an informed user to build their stack knowingly.

Mechanism: 3 antioxidants, 3 distinct logics

N-acetylcysteine (NAC). Direct precursor of intracellular glutathione. Classic oral intake 600 to 1,200 mg/day. NAC crosses the digestive barrier, deacetylates to cysteine, then feeds the synthesis of endogenous glutathione via glutathione synthetase. Documented effect on pulmonary mucus production, hepatic protection in paracetamol overdose, interest in psychiatry for certain OCDs. Selectivity: low. NAC feeds a generic pathway that acts on the whole cellular oxidant pool, without distinguishing useful from deleterious species.

Glutathione (oral or liposomal). Cysteine-glycine-glutamate tripeptide. It is the major physiological intracellular antioxidant. The challenge is bioavailability: the classic oral form is largely hydrolysed in the intestine. Liposomal forms improve measured plasma bioavailability, but actual intracellular penetration remains debated. Selectivity: strong inside cells, but exogenous intake struggles to reach target compartments (brain, mitochondria) in most consumer preparations.

Molecular hydrogen (H₂). The smallest molecule in existence. Diffuses freely across any biological membrane, including the blood-brain barrier and inner mitochondrial membranes. Bioavailability essentially immediate after ingestion of hydrogen water. Selectivity: this is the point identified by Ohsawa et al. (2007) in the founding publication. H₂ reacts preferentially with the hydroxyl radical (•OH) and peroxynitrite (ONOO⁻) — the two oxidative species most deleterious to proteins, lipids and DNA — without neutralising useful signalling species such as H₂O₂ or physiological NO.

This selectivity distinguishes H₂ from NAC and exogenous glutathione. Iuchi et al. (2016) confirmed in vivo that H₂ does not disrupt normal redox-signalling pathways, unlike high intakes of generic antioxidants that can blunt certain exercise adaptations (effect described by Ristow for vitamin C/E at high doses).

Summary comparison

Protocol: can the three be combined?

The three molecules act on different biological levels and their combination raises no known pharmacological interaction. Several advanced HYDROGENYX users build a complete redox stack under a layered logic.

Basic metabolic layer. NAC 600 mg morning and evening during metabolic-stress cycles (winter, training overload, chronic stress periods). No unlimited continuous use, rather cycles of 6 to 8 weeks.

Targeted cellular layer. Liposomal glutathione at bedtime if blood work documents low glutathione. Not systematic.

Daily redox layer. ELITE 9K water, 2-3 glasses 750 mL/day, continuously year-round. This is the maintenance layer that does not disrupt normal signalling and provides chronic selective cleaning.

Why 9,000 PPB. To observe a documented selective activity as in Ohsawa and Iuchi, dissolved concentrations above 800 PPB must be reached. Consumer generators often peak at 400-600 PPB. ELITE 9K delivers 9,000 PPB DPD-validated on every cycle, the necessary margin to compensate for degradation between generation and ingestion and ensure an effective cellular dose.

Client case: Camille, 35, informed biohacker

Camille D., a digital-health consultant based in Paris, monitors her oxidative profile via quarterly private blood work (urinary 8-OHdG, blood glutathione, isoprostanes). She tested the three molecules sequentially, not simultaneously, to isolate effects.

"NAC 1,200 mg/day for 8 weeks: 8-OHdG down 19%, but subjective sensation of energetic plateau at the end of the cycle, perhaps linked to the signalling blunting described in the literature."

"Liposomal glutathione 500 mg/day for 8 weeks: blood glutathione up 14%, 8-OHdG stable. Debatable cost/effect ratio for my profile."

"ELITE 9K water continuously for 14 months: cumulative gradual 8-OHdG decrease of 26%, sleep quality measured by Oura stable high, no perceptible subjective blunting effect. It's the layer I kept permanently."

Limits and nuances

This comparison describes mechanisms and user observations. None of the three molecules is a drug in the strict sense (NAC is used pharmacologically in very targeted indications, but its preventive daily intake belongs to dietary supplements). Clinical evidence on hard markers (mortality, cancer incidence) remains absent or limited for all three.

NAC can interact with some treatments (nitrates, high-dose anticoagulants). Glutathione can interfere with some chemotherapies (oncologist's opinion mandatory). H₂ has no documented drug interaction to date, but this lack of signal does not imply lack of effect.

H₂ audience not recommended. No documented absolute contraindication. Pregnant or breastfeeding women: as a precaution, validate use with the treating physician. Children: insufficient data, to be avoided.

Build your redox layer with ELITE 9K

ELITE 9K is designed for this logic of daily maintenance layer: 9,000 PPB H₂ measured by DPD on every cycle, independent validation by Laboratoire Michel de Lyon, 5-7 day battery life. Assembled in our Lyon 7^th workshop, 5-year parts-and-labour warranty, 60-day satisfied-or-refunded.

1,988 verified reviews, 4.7/5 average, 320+ studies referenced, 7 editorial cornerstones available to dig deeper into each mechanism.

Discover ELITE 9K · Read the cornerstones

Article written by Paul Fournier, founder of HYDROGENYX. France, Lyon 7^th workshop. This article is not medical advice. Any introduction of a dietary supplement in a person on treatment must be validated by a healthcare professional.